4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-22-027649
Director bought 318 shares at an average $2.61 ($830)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jones James Director | 2022-04-14 | Purchase | +28 | $2.71 | $76 | 20,393 | D |
| Jones James Director | 2022-04-18 | Purchase | +28 | $2.63 | $74 | 20,421 | D |
| Jones James Director | 2022-04-19 | Purchase | +28 | $2.69 | $75 | 20,449 | D |
| Jones James Director | 2022-04-20 | Purchase | +28 | $2.74 | $77 | 20,477 | D |
| Jones James Director | 2022-04-21 | Purchase | +28 | $2.75 | $77 | 20,505 | D |
| Jones James Director | 2022-04-22 | Purchase | +28 | $2.73 | $76 | 20,533 | D |
| Jones James Director | 2022-04-25 | Purchase | +30 | $2.62 | $79 | 20,563 | D |
| Jones James Director | 2022-04-26 | Purchase | +30 | $2.53 | $76 | 20,593 | D |
| Jones James Director | 2022-04-27 | Purchase | +30 | $2.41 | $72 | 20,623 | D |
| Jones James Director | 2022-04-28 | Purchase | +30 | $2.51 | $75 | 20,653 | D |
| Jones James Director | 2022-04-29 | Purchase | +30 | $2.44 | $73 | 20,683 | D |
| Open-market purchases · 318 sh · avg $2.61 · $830 | |||||||
Loading xslF345X03/doc4.xml…